Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neuroblastoma 4Central Nervous System Neoplasms 3Small Cell Lung Carcinoma 2Sarcoma 2Ovarian Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Multiple Myeloma 2Lung Neoplasms 2Leukemia 2Hodgkin Disease 2Brain Neoplasms 2Teratoma 1Seminoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Germ Cell Cancer 1Nonseminomatous germ cell tumor 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Unknown Primary 1Neoplasms 1Nasopharyngeal Neoplasms 1Malignant mesenchymal tumor 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1

Interventions

Vincristine 2Ifosfamide 2Etoposide 2Doxorubicin 2Cyclophosphamide 2Busulfan 2treosulfan 1ganitumab 1etoposide phosphate 1Zoledronic Acid 1Triptorelin Pamoate 1Temozolomide 1Radiosurgery 1Radiation 1Melphalan 1Irinotecan 1FANG vaccine 1Diphosphonates 1Dactinomycin 1Cyproheptadine 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Sarcoma, Ewing × etoposide phosphate × Clear all
NCT02306161 2026-05-27

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
312 enrolled 14 charts
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡